Details for New Drug Application (NDA): 063293
✉ Email this page to a colleague
NDA 063293 describes CEFOTAN, which is a drug marketed by Pai Holdings Pharm and Teligent and is included in three NDAs. It is available from one supplier. Additional details are available on the CEFOTAN profile page.
The generic ingredient in CEFOTAN is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
The generic ingredient in CEFOTAN is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
Summary for 063293
| Tradename: | CEFOTAN |
| Applicant: | Teligent |
| Ingredient: | cefotetan disodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063293
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Apr 29, 1993 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Apr 29, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
